Cambridge Financial Group Inc. cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 71,435 shares of the company’s stock after selling 1,321 shares during the quarter. Cardinal Health comprises approximately 3.0% of Cambridge Financial Group Inc.’s portfolio, making the stock its 22nd biggest position. Cambridge Financial Group Inc.’s holdings in Cardinal Health were worth $5,566,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Cardinal Health by 31.8% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after acquiring an additional 382 shares in the last quarter. JFS Wealth Advisors LLC increased its holdings in shares of Cardinal Health by 14.3% during the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after acquiring an additional 244 shares in the last quarter. Dupont Capital Management Corp bought a new position in shares of Cardinal Health during the second quarter valued at $164,000. First Personal Financial Services increased its holdings in shares of Cardinal Health by 127.5% during the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after acquiring an additional 1,238 shares in the last quarter. Finally, Sun Life Financial INC increased its holdings in shares of Cardinal Health by 16,228.6% during the second quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock valued at $178,000 after acquiring an additional 2,272 shares in the last quarter. Hedge funds and other institutional investors own 87.98% of the company’s stock.

WARNING: “Cambridge Financial Group Inc. Has $5.57 Million Stake in Cardinal Health, Inc. (CAH)” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.watchlistnews.com/cambridge-financial-group-inc-has-5-57-million-stake-in-cardinal-health-inc-cah/1630784.html.

Cardinal Health, Inc. (CAH) traded down 2.07% on Friday, hitting $64.96. The stock had a trading volume of 3,742,352 shares. Cardinal Health, Inc. has a 12 month low of $62.70 and a 12 month high of $84.88. The company’s 50 day moving average is $67.23 and its 200-day moving average is $72.86. The stock has a market cap of $20.56 billion, a P/E ratio of 16.12 and a beta of 0.86.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. Cardinal Health’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 earnings per share. Analysts forecast that Cardinal Health, Inc. will post $4.95 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a $0.4624 dividend. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.85%. Cardinal Health’s dividend payout ratio (DPR) is presently 45.79%.

Several equities research analysts recently commented on CAH shares. Zacks Investment Research downgraded Cardinal Health from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Evercore ISI reiterated an “outperform” rating on shares of Cardinal Health in a report on Tuesday, July 4th. BidaskClub downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 11th. Credit Suisse Group reiterated an “outperform” rating and issued a $87.00 price objective (up from $81.00) on shares of Cardinal Health in a report on Thursday, July 13th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a report on Thursday, July 27th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $76.54.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.